Reinstatement
Direct Oral Anticoagulants Compared With Dalteparin for Treatment of Cancer-Associated Thrombosis: A Living, Interactive Systematic Review and Network Meta-analysis
Paper Information
Record ID:
30194
Author(s):
Journal:
Publication Date:
June 22, 2021
Retraction Date:
June 27, 2021
(4.4 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- Mayo Clinic, Rochester, MN
- Dow University of Health Sciences, Karachi, Pakistan
- Banner University Medical Center, University of Arizona, Tucson, AZ
- Pritzker School of Medicine, University of Chicago, Chicago, IL
- Mayo Clinic, Phoenix, AZ
- Innlandet Hospital Trust, Division Gjøvik, Norway
- University of Kansas School of Medicine, Wichita
Countries:
Article Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Reinstatement Details
Retraction Reasons:
Nature of Retraction:
Reinstatement
Retraction Notice:
10.1016/j.mayocp.2020.10.041Additional Notes:
date of retraction unknown, html page overwrite - date estimated from notifications; reason for temporary removal unknown; article now reinstated, unknown date of occurrence. (1/25/22 AJA)
Citations (23)
23
Total Citations23
Post-Retraction(100.0%)
0
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
14
After 2+ years
1291
Days since retraction (latest)
Efficacy and safety of anticoagulants on venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trials
Weijie Fu, Maolin Zhao, Sheng Ding et al. (12 authors)
Frontiers in Pharmacology
Open Access
Published: Jan 2025
1291 days after retraction
Thromboembolism in Patients with Cancer: A Practical Guide to Recurrent Events
Sergey Kozhukhov, Nataliia Dovganych
Reviews in Cardiovascular Medicine
Open Access
Published: Nov 2024
1241 days after retraction
A living critical interpretive synthesis to yield a framework on the production and dissemination of living evidence syntheses for decision-making
Cristián Mansilla, Qi Wang, Thomas Piggott et al. (8 authors)
Implementation Science
Open Access
Published: Sep 2024
1 citation
1 citation
1188 days after retraction
SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023)
Laura Ortega, Francisco José Pelegrín Mateo, Rut Porta Balanyà et al. (10 authors)
Clinical & Translational Oncology
Open Access
Published: Aug 2024
3 citations
3 citations
1137 days after retraction
Edoxaban, Rivaroxaban, or Apixaban for Cancer-Associated Venous Thromboembolism in the Real World: Insights from the COMMAND VTE Registry-2
Daisuke Sueta, Yugo Yamashita, Takeshi Morimoto et al. (35 authors)
Thrombosis and Haemostasis
Published: Apr 2024
3 citations
3 citations
1037 days after retraction
Venous thrombosis during systemic antitumor therapy: risks, prognosis, treatment. A review
М. Yu. Fedyanin, А. А. Rumyantsev, А. А. Tryakin
Journal of Modern Oncology
Open Access
Published: Mar 2024
982 days after retraction
Anticoagulation in venous thromboembolism for the general physician
Katherine Stark, Abhinav Mathur, Mohammed Khan
The Journal of the Royal College of Physicians of Edinburgh
Published: Mar 2024
2 citations
2 citations
978 days after retraction
The impact of renal function on clinical outcomes of patients with cancer-associated isolated distal deep vein thrombosis: Insights from the ONCO DVT study
Daisuke Sueta, Yugo Yamashita, Takeshi Morimoto et al. (24 authors)
Thrombosis Research
Published: Feb 2024
5 citations
5 citations
950 days after retraction
Effectiveness and Safety of Anticoagulants Among Patients with Venous Thromboembolism and Common Cancers or Cancers with High Venous Thromboembolism Risk
Alexander T. Cohen, Virginia Noxon, Amol Dhamane et al. (7 authors)
Future Oncology
Open Access
Published: Jan 2024
927 days after retraction
Long‑term control in a patient with lung adenocarcinoma, nonbacterial thrombotic endocarditis and multiple systemic emboli: A case report
Takeshi Kawakami, Yuika Sasatani, Sachie Hasegawa et al. (9 authors)
Experimental and Therapeutic Medicine
Open Access
Published: Jan 2024
1 citation
1 citation
921 days after retraction
Efficacy and Safety of Apixaban versus Dalteparin as a Treatment for Cancer-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis
Miguel A. Arce-Huamaní, Joshuan J. Barboza, José Fabián Martínez‐Herrera et al. (5 authors)
Medicina
Open Access
Published: Oct 2023
1 citation
1 citation
845 days after retraction
Risk Factors for Bleeding in Cancer Patients Treated with Conventional Dose Followed by Low-Dose Apixaban for Venous Thromboembolism
Parwana Hussaini, Trine‐Lise Larsen, Waleed Ghanima et al. (4 authors)
Thrombosis and Haemostasis
Published: Oct 2023
4 citations
4 citations
835 days after retraction
The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis: a systematic review and meta-analysis
Marte A.M van Hylckama Vlieg, Kazem Nasserinejad, Chantal Visser et al. (23 authors)
EClinicalMedicine
Open Access
Published: Sep 2023
18 citations
18 citations
803 days after retraction
Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding
Kimberly Snow Caroti, Cecilia Becattini, Marc Carrier et al. (14 authors)
TH Open
Open Access
Published: Jul 2023
8 citations
8 citations
734 days after retraction
Safety and Effectiveness of Direct Oral Anticoagulants for the Treatment of Gastrointestinal Cancer-Associated Venous Thromboembolism
Fauzia Ullah, Juhee Song, Cristhiam M. Rojas‐Hernandez et al. (6 authors)
The Oncologist
Open Access
Published: Jun 2023
4 citations
4 citations
716 days after retraction
Proposed triggers for retiring a living systematic review
M. Hassan Murad, Zhen Wang, Haitao Chu et al. (10 authors)
BMJ evidence-based medicine
Open Access
Published: Mar 2023
9 citations
9 citations
619 days after retraction
Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism
Yijun Song, Dawei Yang, Dongni Hou et al. (5 authors)
Thrombosis Journal
Open Access
Published: Feb 2023
2 citations
2 citations
585 days after retraction
A consensus viewpoint on the role of direct factor Xa inhibitors in the management of cancer-associated venous thromboembolism in the UK
Alexander T. Cohen, Gary Benson, Charlotte Bradbury et al. (15 authors)
Current Medical Research and Opinion
Open Access
Published: Jan 2023
1 citation
1 citation
563 days after retraction
Prevention, Diagnostics and Treatment of Deep Vein Thrombosis. Russian Experts Consensus
E.I. Seliverstov, Kirill Lobastov, Е.А. Ilyukhin et al. (84 authors)
Journal of Venous Disorders
Published: Jan 2023
40 citations
40 citations
553 days after retraction
Multidisciplinary Care for the Prevention and Treatment of Venous Thromboembolism in Patients with Cancer-Associated Thrombosis (CAT): Impact of Educational Interventions on CAT-Related Events and on Patients’ and Clinicians’ Awareness
Beniamino Zalunardo, Chiara Panzavolta, Paola Bigolin et al. (4 authors)
Life
Open Access
Published: Oct 2022
6 citations
6 citations
473 days after retraction
Development of a Website for a Living Network Meta-analysis of Atopic Dermatitis Treatments Using a User-Centered Design: Multimethod Study
Karen P. L. Lau, Payal Agarwal, Laura Parente et al. (13 authors)
JMIR Dermatology
Open Access
Published: Sep 2022
2 citations
2 citations
456 days after retraction
Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism
Yijun Song, Dawei Yang, Dongni Hou et al. (5 authors)
Research Square (Research Square)
Open Access
Published: Sep 2022
452 days after retraction
Safety of Direct Acting Oral Anticoagulants (DOACs) in Comparison to Enoxaparin in Gastrointestinal and Genito-Urinary Cancers
Shafia Rahman, Juan Trias, Mohammad Barouqa et al. (5 authors)
SSRN Electronic Journal
Published: Jan 2022
188 days after retraction
Quick Stats
Total Citations:
23
Years Since Retraction:
4.4 years
Open Access:
Yes
Last Checked:
Jul 24, 2025